Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes

International Journal of Molecular Medicine

Volumn 31, Issue 6, 2013, Pages 1429-1435

  Yang, Junpeng ^a   Ren, Jianmin ^a   Song, Jun ^a   Liu, Fuqiang ^a   Wu, Chuanlong ^a   Wang, Xuping ^b   Gong, Lei ^a   Li, Wenjuan ^a   Xiao, Fang ^a   Yan, Fei ^a   Hou, Xinguo ^a   Chen, Li ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Adipogenesis; Akt; Glucagon like peptide 1

Indexed keywords

BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN ALPHA; FAT DROPLET; FREE FATTY ACID BINDING PROTEIN 4; GLUCAGON LIKE PEPTIDE 1; LIPOPROTEIN LIPASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ADIPOGENESIS; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; STAINING;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL SURVIVAL; GLUCAGON-LIKE PEPTIDE 1; LIPID METABOLISM; MAP KINASE SIGNALING SYSTEM; MICE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84876362365     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2013.1350     Document Type: Article

References (31)

1. Hossain P, Kawar B and El Nahas M: Obesity and diabetes in the developing world -a growing challenge. N Engl J Med 356: 213-215, 2007. (Pubitemid 46143224)
2. Shi H, Akunuru S, Bierman JC, et al: Diet-induced obese mice are leptin insufficient after weight reduction. Obesity 17: 1702-1709, 2009.
3. Seale P and Lazar MA: Brown fat in humans: turning up the heat on obesity. Diabetes 58: 1482-1484, 2009.
4. Dahlman I and Arner P: Obesity and polymorphisms in genes regulating human adipose tissue. Int J Obes 31: 1629-1641, 2007. (Pubitemid 350023156)
5. Sun K, Kusminski CM and Scherer PE: Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101, 2011.
6. Cristancho AG and Lazar MA: Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734, 2011.
7. Spalding KL, Arner E, Westermark PO, et al: Dynamics of fat cell turnover in humans. Nature 453: 783-787, 2008. (Pubitemid 351793777)
8. Tchoukalova YD, Votruba SB, Tchkonia T, et al: Regional differences in cellular mechanisms of adipose tissue gain with overfeeding. Proc Natl Acad Sci USA 107: 18226-18231, 2010.
9. Hoffstedt J, Arner E, Wahrenberg H, et al: Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 53: 2496-2503, 2010.
10. Koenen TB, Tack CJ, Kroese JM, et al: Pioglitazone treatment enlarges subcutaneous adipocytes in insulin-resistant patients. J Clin Endocrinol Metab 94: 4453-4457, 2009.
11. Veilleux A, Caron-Jobin M, Noel S, et al: Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60: 1504-1511, 2011.
12. Meier JJ: GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nat Rev Endocrinol 8: 728-742, 2012.
13. Kielgast U, Holst JJ and Madsbad S: Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual ?-cell function. Diabetes 60: 1599-1607, 2011.
14. Ben-Shlomo S, Zvibel I, Shnell M, et al: Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. J Hepatol 54: 1214-1223, 2011.
15. Chai W, Dong Z, Wang N, et al: Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 61: 888-896, 2012.
16. Gao H, Wang X, Zhang Z, et al: GLP-1 amplifies insulin signaling by up-regulation of IR?, IRS-1 and Glut4 in 3T3-L1 adipocytes. Endocrine 32: 90-95, 2007. (Pubitemid 350242552)
17. Lee YS, Park MS, Choung JS, et al: Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 55: 2456-2468, 2012.
18. He M, Su H, Gao W, et al: Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese mice. PLoS One 5: e14205, 2010.
19. Bass J and Takahashi JS: Circadian integration of metabolism and energetics. Science 330: 1349-1354, 2010.
20. Cristancho AG and Lazar MA: Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12: 722-734, 2011.
21. Kim GS, Park HJ, Woo JH, et al: Citrus aurantium flavonoids inhibit adipogenesis through the Akt signaling pathway in 3T3-L1 cells. BMC Complement Altern Med 12: 31, 2012.
22. Choi SS, Cha BY, Iida K, et al: Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes. J Nat Med 65: 424-430, 2011.
23. Zhang M, Ikeda K, Xu JW, et al: Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways. Phytother Res 23: 713-718, 2009.
24. Fischer-Posovszky P, Tews D, Horenburg S, et al: Differential function of Akt1 and Akt2 in human adipocytes. Mol Cell Endocrinol 358: 135-143, 2012.
25. Polvani S, Tarocchi M and Galli A: PPAR? and oxidative stress: Con(?) catenating NRF2 and FOXO. PPAR Res 2012: 641087, 2012.
26. Dowell P, Otto TC, Adi S and Lane MD: Convergence of peroxisome proliferator-activated receptor ? and foxo1 signaling pathways. J Biol Chem 278: 45485-45491, 2003. (Pubitemid 37432687)
27. Sanz C, Vázquez P, Blázquez C, Barrio PA, Alvarez Mdel M and Blázquez E: Signaling and biological effects of glucagon-like peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow. Am J Physiol Endocrinol Metab 298: E634-E643, 2010.
28. Challa TD, Beaton N, Arnold M, et al: Regulation of adipocyte formation by GLP-1/GLP-1R signaling. J Biol Chem 287: 6421-6430, 2012.
29. Kang JG, Park CY, Ihm SH, et al: Mechanisms of adipose tissue redistribution with rosiglitazone treatment in various adipose depots. Metabolism 59: 46-53, 2010.
30. Dubuisson O, Dhurandhar EJ, Krishnapuram R, et al: PPARgamma-independent increase in glucose uptake and adiponectin abundance in fat cells. Endocrinology 152: 3648-3660, 2011.
31. Chang YC and Cho HJ: Ascofuranone stimulates expression of adiponectin and peroxisome proliferator activated receptor through the modulation of mitogen activated protein kinase family members in 3T3-L1, murine pre-adipocyte cell line. Biochem Biophys Res Commun 422: 423-428, 2012.